Patents by Inventor Prajit Limsirichai

Prajit Limsirichai has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • RECOMBINANT VACCINIA VIRUS
    Publication number: 20230201283
    Abstract: The present disclosure provides a replication-competent, recombinant oncolytic vaccinia virus (RVV), compositions comprising the RVV, and use of the RVV or composition for inducing oncolysis in an individual having a tumor.
    Type: Application
    Filed: January 5, 2021
    Publication date: June 29, 2023
    Inventors: Joseph John Binder, Michael Dale Eisenbraun, Douglas Hanahan, David H. Kirn, Clare Lees, Prajit Limsirichai, Liliana Maruri Avidal
  • Recombinant vaccinia virus and methods of use thereof
    Patent number: 11685904
    Abstract: The present disclosure provides a replication-competent, recombinant oncolytic vaccinia virus, compositions comprising the vaccinia virus, and use of the vaccinia virus or composition for inducing oncolysis in an individual having a tumor.
    Type: Grant
    Filed: February 10, 2020
    Date of Patent: June 27, 2023
    Assignee: Ignite Immunotherapy, Inc.
    Inventors: David H. Kirn, Liliana Maruri Avidal, Prajit Limsirichai
  • RECOMBINANT VACCINIA VIRUS AND METHODS OF USE THEREOF
    Publication number: 20200263145
    Abstract: The present disclosure provides a replication-competent, recombinant oncolytic vaccinia virus, compositions comprising the vaccinia virus, and use of the vaccinia virus or composition for inducing oncolysis in an individual having a tumor.
    Type: Application
    Filed: February 10, 2020
    Publication date: August 20, 2020
    Applicant: Ignite Immunotherapy, Inc.
    Inventors: David H. Kirn, Liliana Maruri Avidal, Prajit Limsirichai